Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-29

Clinical Trial Update: Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease. [NA]

View source ↗

Summary

This clinical trial update examines omega-3 fatty acids supplementation and its effect on atherothrombotic biomarkers in individuals with Type 2 diabetes mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids supplement (Omega-3 fatty acids)

Snippet

Sponsor: Jagiellonian University | Conditions: Type 2 Diabetes, Cardiovascular Diseases | NA | Status: COMPLETED